Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6292423rdf:typepubmed:Citationlld:pubmed
pubmed-article:6292423lifeskim:mentionsumls-concept:C0014940lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C0019467lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C1524075lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C0068008lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C0030866lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C1149369lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:6292423lifeskim:mentionsumls-concept:C0337112lld:lifeskim
pubmed-article:6292423pubmed:issue11lld:pubmed
pubmed-article:6292423pubmed:dateCreated1983-1-19lld:pubmed
pubmed-article:6292423pubmed:abstractTextA series of nonsteroidal, side-chain functionalized estrogens based on (3R*,4S*)-3,4-bis(4-hydroxyphenyl)hexane (hexestrol) and (2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentane (norhexestrol) has been prepared; these include amide, diazo ketone, ester, alcohol, ketone, fluoro, bromo, iodo, and saturated hydrocarbon derivatives. Analysis of the binding affinity of these compounds to the uterine estrogen receptor, measured by competitive binding assay, reveals trends that can be related to the steric size, the hydrophobicity, and the hydrogen bond accepting character of the side-chain substituents. Comparison of binding affinities between norhexestrol and hexestrol derivatives indicates that, in general, the norhexestrols show significantly higher receptor binding affinities, making this series of compounds ideally suited as functional probes for the estrogen receptor.lld:pubmed
pubmed-article:6292423pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292423pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292423pubmed:languageenglld:pubmed
pubmed-article:6292423pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292423pubmed:citationSubsetIMlld:pubmed
pubmed-article:6292423pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292423pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292423pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292423pubmed:statusMEDLINElld:pubmed
pubmed-article:6292423pubmed:monthNovlld:pubmed
pubmed-article:6292423pubmed:issn0022-2623lld:pubmed
pubmed-article:6292423pubmed:authorpubmed-author:Katzenellenbo...lld:pubmed
pubmed-article:6292423pubmed:authorpubmed-author:LandvatterS...lld:pubmed
pubmed-article:6292423pubmed:issnTypePrintlld:pubmed
pubmed-article:6292423pubmed:volume25lld:pubmed
pubmed-article:6292423pubmed:ownerNLMlld:pubmed
pubmed-article:6292423pubmed:authorsCompleteYlld:pubmed
pubmed-article:6292423pubmed:pagination1300-7lld:pubmed
pubmed-article:6292423pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:meshHeadingpubmed-meshheading:6292423-...lld:pubmed
pubmed-article:6292423pubmed:year1982lld:pubmed
pubmed-article:6292423pubmed:articleTitleNonsteroidal estrogens: synthesis and estrogen receptor binding affinity of derivatives of (3R*,4S*)-3,4-bis(4-hydroxyphenyl)hexane (hexestrol) and (2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentane (norhexestrol) functionalized on the side chain.lld:pubmed
pubmed-article:6292423pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6292423pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:6292423pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:6292423lld:chembl